Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.
Wells JM, Titlestad IL, Tanash H, Turner AM, Chapman KR, Hatipoğlu UŞ, Goldklang MP, D'Armiento JM, Pirozzi CS, Drummond MB, Barjaktarevic IZ, Chatila WM, Devine MS, Strange C, Sandhaus RA, Parkin JM, Westfall E, Lin VY, Parks R, Kuo HC, Ekue A, Moffitt KL, Inshaw J, Aban I, Dransfield MT, Stockley RA.
Wells JM, et al.
Eur Respir J. 2025 Dec 18;66(6):2501019. doi: 10.1183/13993003.01019-2025. Print 2025 Dec.
Eur Respir J. 2025.
PMID: 40967767
Free PMC article.
Clinical Trial.